Covered recipient · General Payments record
ASHLEY M WARMOTH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$2,461.48
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $296.31 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $75.48 | 4 |
| Novo Nordisk AS | $61.70 | 3 |
| Acerta Pharma LLC | $48.66 | 3 |
| PFIZER INC. | $36.10 | 2 |
| ABBVIE INC. | $35.45 | 2 |
| Esperion Therapeutics, Inc. | $24.71 | 1 |
| Lilly USA, LLC | $14.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.84 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106309272 | CMS |
| ABBVIE INC. | $15.61 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106309274 | CMS |
| Amgen Inc. | $19.50 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117410858 | CMS |
| Amgen Inc. | $14.38 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117410860 | CMS |
| Amgen Inc. | $18.16 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117410862 | CMS |
| Amgen Inc. | $23.44 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111736234 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.68 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104473052 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.61 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104465160 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.37 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104529238 | CMS |
| Esperion Therapeutics, Inc. | $24.71 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129459460 | CMS |
| Lilly USA, LLC | $14.21 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136055634 | CMS |
| Novo Nordisk Inc | $23.55 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097312155 | CMS |
| Novo Nordisk Inc | $19.22 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096724153 | CMS |
| Novo Nordisk Inc | $18.93 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096971854 | CMS |
| PFIZER INC. | $19.99 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131441382 | CMS |
| PFIZER INC. | $16.11 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131757768 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.